Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


BioProspect's Termilone advances

The Australian biotechnology company, BioProspect (Brisbane, Queensland), hopes to receive Australian approval for its eremophilone oil-based termiticide, Termilone, within 12 months. The Australian Pesticides and Veterinary Medicines Authority has completed a preliminary assessment of the active ingredient, which qualifies for an eight-month review, BioProspect notes. The reduction from the 13 months for ais requiring greater toxicological assessment is an “excellent outcome”, says BioProspect’s chief executive officer, Peter May. It will result in reduced registration costs, he adds.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts